|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/071 | |
| C12N 5/079 | |||
| C07K 14/78 |
| (11) | Number of the document | 3400287 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17704327.0 |
| Date of filing the European patent application | 2017-01-03 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/012061 |
| Date | 2017-01-03 |
| (87) | Number | WO 2017/120147 |
| Date | 2017-07-13 |
| (30) | Number | Date | Country code |
| 201662274700 P | 2016-01-04 | US | |
| 201662414533 P | 2016-10-28 | US |
| (72) |
SIPRASHVILI, Zurab, US
NGUYEN, Ngon T., US
MARINKOVICH, M. Peter, US
TANG, Jean, US
LANE, Alfred T., US
KHAVARI, Paul A., US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
U.S. Government as represented by the Department of Veterans Affairs, 810 Vermont Avenue, Washington, DC 20420, US |
| (54) | GENE THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA USING GENETICALLY CORRECTED AUTOLOGOUS KERATINOCYTES |
| GENE THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA USING GENETICALLY CORRECTED AUTOLOGOUS KERATINOCYTES |